Sheila DeWitt,Vincent Jacques,Leonardus van der Ploeg
申请号：
US16567445
公开号：
US20200239457A1
申请日:
2019.09.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention provides deuterium-enriched thiazolidine-2,4-dione compounds (i.e., deuterium-enriched glitazone compounds), enantiopure forms of deuterium-enriched glitazone compounds, pharmaceutical compositions, and methods of treating medical disorders, such as a metabolic disorder, neurological disorders, cancer, or other disorder using deuterium-enriched glitazone compounds, which may be in enantiopure form.
